title: A machine learning-based method to improve docking scoring functions and its application to drug repurposing.
abstract: Docking scoring functions are notoriously weak predictors of binding affinity. They typically assign a common set of weights to the individual energy terms that contribute to the overall energy score; however, these weights should be gene family dependent. In addition, they incorrectly assume that individual interactions contribute toward the total binding affinity in an additive manner. In reality, noncovalent interactions often depend on one another in a nonlinear manner. In this paper, we show how the use of support vector machines (SVMs), trained by associating sets of individual energy terms retrieved from molecular docking with the known binding affinity of each compound from high-throughput screening experiments, can be used to improve the correlation between known binding affinities and those predicted by the docking program eHiTS. We construct two prediction models: a regression model trained using IC(50) values from BindingDB, and a classification model trained using active and decoy compounds from the Directory of Useful Decoys (DUD). Moreover, to address the issue of overrepresentation of negative data in high-throughput screening data sets, we have designed a multiple-planar SVM training procedure for the classification model. The increased performance that both SVMs give when compared with the original eHiTS scoring function highlights the potential for using nonlinear methods when deriving overall energy scores from their individual components. We apply the above methodology to train a new scoring function for direct inhibitors of Mycobacterium tuberculosis (M.tb) InhA. By combining ligand binding site comparison with the new scoring function, we propose that phosphodiesterase inhibitors can potentially be repurposed to target M.tb InhA. Our methodology may be applied to other gene families for which target structures and activity data are available, as demonstrated in the work presented here.
authors.affiliation: Institute of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.
authors.forename: Sarah L
authors.initials: SL
authors.lastname: Kinnings
authors.forename: Nina
authors.initials: N
authors.lastname: Liu
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Tonge
authors.forename: Richard M
authors.initials: RM
authors.lastname: Jackson
authors.forename: Lei
authors.initials: L
authors.lastname: Xie
authors.forename: Philip E
authors.initials: PE
authors.lastname: Bourne
mesh_terms: D000465:Algorithms; D001665:Binding Sites; D055808:Drug Discovery / Q000379:methods*; D058492:Drug Repositioning; D050753:Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) / Q000037:antagonists & inhibitors / Q000737:chemistry; D006801:Humans; D008024:Ligands; D008958:Models, Molecular; D010726:Phosphodiesterase Inhibitors / Q000737:chemistry; D010727:Phosphoric Diester Hydrolases / Q000737:chemistry; D012984:Software; D060388:Support Vector Machine
chemical_list: D008024:Ligands; D010726:Phosphodiesterase Inhibitors; D050753:Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); D010727:Phosphoric Diester Hydrolases